Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
A Study of CC-98633 BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed and/or Refractory Multiple Myeloma

The dose-escalation part (Part A) of the study is to evaluate the safety and tolerability of increasing dose levels of CC-98633 to establish a recommended Phase 2 dose (RP2D); and the dose-expansion part (Part B) of the study is to further evaluate the safety, pharmacokinetics/pharmacodynamics, and efficacy of CC-98633 at …

thalidomide
bcma
immunotherapeutic agent
multiple myeloma
daratumumab
  • 0 views
  • 19 Feb, 2024
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors

Stereotactic radiotherapy is a recent technique proposed to hepatic metastases treatment from solid cancers and primary hepatic lesions (HCC or cholangiocarcinomas); it is possible to deliver high doses of radiation in the most conformational way possible in order to limit the irradiation of the non-tumor liver.

liver diseases
chelates
skin cancer
stereotactic radiation therapy
colorectal cancer
  • 0 views
  • 19 Feb, 2024
Prospective Register on the Etiologies of Cardiogenic Shock and Their Prognosis at One Year.

This definition of the European Society of Cardiology (ESC) masks however the great variability of hemodynamic tables grouped under the term of CC and severity levels, also variable.However, it was suggested that the etiology of CC influenced both its hemodynamic profile and therefore its therapeutic management but also its prognosis …

shock
systolic blood pressure
heart failure
hyperlactatemia
vasopressor
  • 0 views
  • 19 Feb, 2024
Saliva as Source of Detection for SARS-CoV-2

Eligibility NIH staff members age 18 and older who are taking part in NIH CC SARS-CoV-2 surveillance. Design The Occupational Medical Service (OMS) collects NP swabs as part of standard NIH staff screening.

discomfort
nasopharyngeal swab
nasal swab
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 19 Feb, 2024
Surveillance of Individuals Following SARS-CoV-2 Exposure

Background People who have had contact with a person with a known SARS-CoV-2 infection are being told to self-quarantine for 14 days. This is done to avoid potential virus spread. But the actual time it takes for a person to develop an infection after being exposed to the virus is …

covid-19
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 19 Feb, 2024
Diagnosis Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter Two-way Non-intervention Study

This is a multicenter, two-way, non-intervention study. the main purpose: Understand the current status of diagnosis and treatment of cholangiocarcinoma patients in China and observe the effect of different treatment options on patient recurrence and long-term survival Secondary purpose: Exploring the actual clinical treatment situation and its compliance with the …

cholangiocarcinoma
cancer
  • 0 views
  • 19 Feb, 2024
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

The main aim of the study is to set up an observational cohort with NAFLD (Non-alcoholic fatty liver disease) at different stage of disease (from simple steatosis to cirrhosis and/or HCC-Hepatocellular carcinoma) and for comparative purpose a cohort of subjects with diabetes and/or obesity and/or other risk factors (i.e. psoriasis, …

cirrhosis
non-alcoholic fatty liver
steatosis
fatty liver
inflammatory bowel disease
  • 0 views
  • 19 Feb, 2024
Non Exudative AMD Imaged With SS-OCT- Extension

The investigators wish to better understand the role of the choriocapillaris (CC) in the formation and progression of non-exudative in age related macular degeneration (armd) by imaging the retinal pigment epithelium (rpe) and the choroidal microvasculature and by studying their inter-dependence to determine if the loss of the CC could …

macular degeneration
maculopathy
retinal pigment
age-related macular degeneration
drug trials
  • 0 views
  • 19 Feb, 2024